Every source of contamination must be considered in biomanufacturing processes, drug formulation, and drug delivery. Potential sources of contamination are single-use systems (SUS) and components. Learn more about potential contamination risks and how to monitor and mitigate them.
Join Mark Bumiller and Joy Xiaohui Chen as they discuss particulate contamination as an important consideration in pharmaceutical production, and even more so in bioprocess production and delivery as well as in ophthalmic applications.
Speaker(s)
- Mark Bumiller | Technology Manager, Entegris Inc.
- Joy Xiaohui Chen | Senior Applications Engineer, Life Sciences Entegris Inc.
Every source of contamination must be considered in biomanufacturing processes, drug formulation, and drug delivery. Potential sources of contamination are single-use systems (SUS) and components. Learn more about potential contamination risks and how to monitor and mitigate them.
Join Mark Bumiller and Joy Xiaohui Chen as they discuss particulate contamination as an important consideration in pharmaceutical production, and even more so in bioprocess production and delivery as well as in ophthalmic applications.
/content/entegris-live/en/home/about-us/events/minimizing-particulate-contamination-in-single-use-systems-select-science-webinarOn Demand Webinar
Several key aspects ofparticle contamination control are reviewed in this webinar:
- Staying ahead of emerging standards
- Technical and regulatory concerns
- Clean manufacturing environments
- Continuous testing